Corcept Therapeutics Inc
CORT· Nasdaq
Released May 1, 2024, after the close
10-Q filed May 1, 2024, 31 days after period end · 0001628280-24-019610
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $146.81M | $105.65M | $93.69M | $79.44M |
| Net Income | $27.76M | $15.88M | $22.80M | $23.47M |
| EPS Diluted |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| $0.25 |
| $0.14 |
| $0.20 |
| $0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.